EUROPE DIGITAL GENOME MARKET 2021-2028

Lifesciences | Healthcare IT

EUROPE DIGITAL GENOME MARKET 2021-2028

Market by Product, Application, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research on the Europe digital genome market depicts that this industry will grow at a CAGR of 9.30% in terms of revenue during the forecast years from 2021 to 2028.


Report scope can be customized per your requirements. Request For Customization

The countries evaluated in the report on this market include:

•           Germany

•           The United Kingdom

•           France

•           Spain

•           Russia

•           Italy

•           Rest of Europe countries

Germany is considered the largest biotechnology hub in Europe and across the world, thanks to the presence of numerous biotechnology companies in the country, high-tech research laboratories, and massive funding to carry out R&D activities. The nation boasts of having the highest number of biotech companies in the region, and is also a prominent name internationally considering the number of studies in the pipeline. The high-quality research infrastructure present in Germany and the cutting-edge technology it uses are creating a lucrative opportunity for the growth of the digital genome market.

Whereas, in France, national-level genomic organizations are working on improving the genomics and bioinformatics platforms in the country. For instance, France Genomique is focused on maintaining high-performance research for the production and analysis of genomics data. The healthcare infrastructure offers superior skills, expertise, and support to the nation’s scientific community. In addition, the International Symposium on Human Genomics was held in France in February 2020 to share the experiences of some of the best French teams working in the field. All the above-stated factors provide a beneficial scenario for the growth of the French digital genome market in the coming years.

Biomeriux SA is a France-based company providing products and solutions for the diagnosis and management of cardiovascular diseases, infectious diseases, and targeted cancers. The healthcare segment of the company caters to pharmaceutical companies, hospitals, medical clinics, dental & orthodontic practitioners, health information systems, and food manufacturing & testing. The company operates through its subsidiaries and a vast network of distributors. BioMerieux is headquartered in Marcy l’Etoile, France. The strong research and development capabilities of the company enable it to develop innovative products to boost revenue. Also, Biomeriux’s investments in R&D have increased, as compared to the previous years.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE DIGITAL GENOME MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1. THREAT OF NEW ENTRANTS

2.1.2. THREAT OF SUBSTITUTE PRODUCTS

2.1.3. BARGAINING POWER OF BUYERS

2.1.4. BARGAINING POWER OF SUPPLIERS

2.1.5. COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET

2.3. MARKET ATTRACTIVENESS INDEX

2.4. VENDOR LANDSCAPE

2.5. KEY INSIGHTS

2.6. KEY DRIVERS

2.6.1. PROLIFERATING BURDEN OF CHRONIC DISEASES

2.6.2. CONTINUOUS FUNDING BY THE MANUFACTURERS AND GOVERNMENT IN THE FIELD OF GENOMICS

2.7. KEY RESTRAINTS

2.7.1. SECURITY RISKS ASSOCIATED WITH DIGITAL GENOME

2.7.2. LACK OF SKILLED PROFESSIONALS IN THE FIELD OF GENOME TECHNOLOGY

2.8. KEY OPPORTUNITIES

2.8.1. TECHNOLOGICAL ADVANCEMENTS

2.8.2. PREVAILING AWARENESS IN THE DEVELOPING ECONOMIES REGARDING DNA SEQUENCING TECHNOLOGIES

3.    DIGITAL GENOME MARKET OUTLOOK - BY PRODUCT

3.1. SEQUENCING AND ANALYZER INSTRUMENTS

3.2. DNA/RNA ANALYSIS

3.3. SEQUENCING AND ANALYSIS SOFTWARE

3.4. SEQUENCING CHIPS

3.5. SAMPLE PREP INSTRUMENTS

4.    DIGITAL GENOME MARKET OUTLOOK - BY APPLICATION

4.1. DIAGNOSTICS

4.2. DRUG DISCOVERY

4.3. ACADEMIC RESEARCH

4.4. PERSONALIZED MEDICINE

4.5. AGRICULTURAL

4.6. OTHER APPLICATIONS

5.    DIGITAL GENOME MARKET OUTLOOK - BY END-USER

5.1. DIAGNOSTICS AND FORENSIC LABS

5.2. ACADEMIC RESEARCH INSTITUTES

5.3. HOSPITALS

5.4. OTHER END-USERS

6.    DIGITAL GENOME MARKET - EUROPE

6.1. COUNTRY ANALYSIS

6.1.1. GERMANY

6.1.2. FRANCE

6.1.3. THE UNITED KINGDOM

6.1.4. ITALY

6.1.5. RUSSIA

6.1.6. SPAIN

6.1.7. REST OF EUROPE

7.    COMPANY PROFILE

7.1. QIAGEN NV

7.2. OXFORD NANOPORE TECHNOLOGIES LTD

7.3. BECTON, DICKINSON, AND COMPANY (BD)

7.4. ILLUMINA INC

7.5. THERMO FISHER SCIENTIFIC INC

7.6. PACIFIC BIOSCIENCE

7.7. BIO-RAD LABORATORIES INC

7.8. F. HOFFMANN-LA ROCHE

7.9. PERKINELMER INC

7.10. REGENERON PHARMACEUTICALS

7.11. BIOMERIEUX SA

7.12. ABBOTT LABORATORIES

7.13. AGILENT TECHNOLOGIES INC.

7.14. INSCRIPTA

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1. OBJECTIVES OF STUDY

8.1.2. SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1. PRIMARY DATA SOURCES

8.2.2. SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1. EVALUATION OF PROPOSED MARKET

8.3.2. IDENTIFICATION OF DATA SOURCES

8.3.3. ASSESSMENT OF MARKET DETERMINANTS

8.3.4. DATA COLLECTION

8.3.5. DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       EUROPE DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR LANDSCAPE

TABLE 3:       EUROPE DIGITAL GENOME MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 4:       EUROPE DIGITAL GENOME MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 5:       EUROPE DIGITAL GENOME MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 6:       EUROPE DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     EUROPE DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     EUROPE DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 3:     EUROPE DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 4:     EUROPE DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 5:     EUROPE DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)

FIGURE 6:     EUROPE DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7:     EUROPE DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 8:     EUROPE DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 9:     EUROPE DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 10:  EUROPE DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 11:  EUROPE DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)

FIGURE 12:  EUROPE DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 13:  EUROPE DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)

FIGURE 14:  EUROPE DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 15:  EUROPE DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 16:  EUROPE DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 17:  EUROPE DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 18:  GERMANY DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 19:  FRANCE DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 20:  THE UNITED KINGDOM DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 21:  ITALY DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 22:  RUSSIA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  SPAIN DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  REST OF EUROPE DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;